Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Aroa Biosurgery.
RELATED STOCKHEAD STORIES
News
Last Orders: ASX returns from Easter break with a gain
News
With America vaccinating 2 million a day, here are 3 ASX medtechs that will benefit as lockdowns are lifted
Experts
ScoPo’s health powerplays: ‘A great start to reporting season for healthcare’
Health & Biotech
Broken bones are no pretty picture but these ASX stocks help you diagnose or fix them
IPO Watch
IPO Watch: Doctor Care Anywhere set to join the ASX telehealth ranks next month
News
Charted: Why fund managers have their eye on these ASX small caps
IPO Watch
The driving forces behind Australia’s red-hot IPO market
News
ASX gold, New Zealand-headquartered small caps take a hit; investors told not to panic
Health & Biotech
Check up: Maybe next week will be better?
News
ASX capital raisings top $30b in 2020 so far
Health & Biotech
Shares in new IPO Aroa Biosurgery have now doubled in a week
IPO Watch
